{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:17:04Z","timestamp":1778721424109,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.heliyon.2024.e38926","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T02:19:57Z","timestamp":1727921997000},"page":"e38926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["miR-4486 inhibits colorectal cancer proliferation via targeting MAP2K4 to inhibit the activation of the p38MAPK\/JNK signaling"],"prefix":"10.1016","volume":"10","author":[{"given":"Weiwei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feipeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qidong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lirui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honghui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e38926_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.heliyon.2024.e38926_bib2","first-page":"145","article-title":"Colorectal cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.heliyon.2024.e38926_bib3","doi-asserted-by":"crossref","first-page":"2019\/01","DOI":"10.3390\/nu11010164","article-title":"Colorectal cancer and nutrition","volume":"11","author":"Thanikachalam","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.heliyon.2024.e38926_bib4","doi-asserted-by":"crossref","first-page":"2021\/03\/03","DOI":"10.3892\/or.2021.7961","volume":"45","author":"Poturnajova","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.heliyon.2024.e38926_bib5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2024.e38926_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gde.2013.01.004","article-title":"miRNA profiling of cancer","volume":"23","author":"Di Leva","year":"2013","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.heliyon.2024.e38926_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0265527","article-title":"Update of gene expression\/methylation and MiRNA profiling in colorectal cancer; application in diagnosis, prognosis, and targeted therapy","volume":"17","author":"Mehrgou","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e38926_bib8","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20176103","article-title":"MicroRNA-455 suppresses the oncogenic function of HDAC2 in human colorectal cancer","volume":"50","author":"Mao","year":"2017","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.heliyon.2024.e38926_bib9","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00432-017-2440-4","article-title":"MicroRNA-30a-5p (miR-30a) regulates cell motility and EMT by directly targeting oncogenic TM4SF1 in colorectal cancer","volume":"143","author":"Park","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.heliyon.2024.e38926_bib10","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3892\/etm.2021.10900","article-title":"miR-4486 reverses cisplatin-resistance of colon cancer cells via targeting ATG7 to inhibiting autophagy","volume":"22","author":"Wang","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.heliyon.2024.e38926_bib11","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1002\/cncr.28864","article-title":"The MAPK pathway across different malignancies: a new perspective","volume":"120","author":"Burotto","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.heliyon.2024.e38926_bib12","first-page":"5323","article-title":"LncRNA SNHG20 promoted the proliferation of glioma cells via sponging miR-4486 to regulate the MDM2-p53 pathway","volume":"23","author":"Liu","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.heliyon.2024.e38926_bib13","doi-asserted-by":"crossref","first-page":"2022\/05","DOI":"10.3892\/mmr.2022.12734","article-title":"Role of metformin in functional endometrial hyperplasia and polycystic ovary syndrome involves the regulation of MEG3\/miR-223\/GLUT4 and SNHG20\/miR-4486\/GLUT4 signaling","volume":"26","author":"Liu","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.heliyon.2024.e38926_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1124\/mol.111.076091","article-title":"Antitumor indolequinones induced apoptosis in human pancreatic cancer cells via inhibition of thioredoxin reductase and activation of redox signaling","volume":"81","author":"Yan","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e38926_bib15","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1152\/physrev.00028.2011","article-title":"Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update","volume":"92","author":"Kyriakis","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.heliyon.2024.e38926_bib16","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1007\/s10620-014-3049-y","article-title":"LPS induced miR-181a promotes pancreatic cancer cell migration via targeting PTEN and MAP2K4","volume":"59","author":"Liu","year":"2014","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.heliyon.2024.e38926_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102289","article-title":"Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis","volume":"9","author":"Pavese","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e38926_bib18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000356679","article-title":"MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells","volume":"33","author":"Pan","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.heliyon.2024.e38926_bib19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1471-2407-11-173","article-title":"Analysis of the mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer","volume":"11","author":"Davis","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.heliyon.2024.e38926_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3892\/ijmm.2016.2826","article-title":"miR-214 suppresses the osteogenic differentiation of bone marrow-derived mesenchymal stem cells and these effects are mediated through the inhibition of the JNK and p38 pathways","volume":"39","author":"Guo","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e38926_bib21","doi-asserted-by":"crossref","first-page":"20451","DOI":"10.1074\/jbc.M311164200","article-title":"Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons","volume":"279","author":"Choi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e38926_bib22","first-page":"981","article-title":"Activation of p38 MAPK and\/or JNK contributes to increased levels of VEGF secretion in human malignant glioma cells","volume":"29","author":"Yoshino","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.heliyon.2024.e38926_bib23","article-title":"Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity","volume":"21","author":"Lee","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e38926_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/2008-2231-21-41","article-title":"Comparative amino acid decomposition analysis of potent type I p38alpha inhibitors","volume":"21","author":"Ebadi","year":"2013","journal-title":"Daru"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024149572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024149572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T06:14:55Z","timestamp":1775456095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024149572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":24,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2405844024149572"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38926","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-4486 inhibits colorectal cancer proliferation via targeting MAP2K4 to inhibit the activation of the p38MAPK\/JNK signaling","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e38926"}}